Protalix BioTherapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Protalix BioTherapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $3.24M.
  • Protalix BioTherapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$9.61M, a 190% decline year-over-year.
  • Protalix BioTherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $8.31M.
  • Protalix BioTherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14.9M, a 45.9% increase from 2021.
  • Protalix BioTherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$27.6M, a 323% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$9.61M $3.24M +$5.09M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$14.7M -$2.2M -$21.5M -111% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $6.85M -$4.6M -$1.46M -46.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $8.31M -$6.04M -$2.3M -61.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $10.6M -$1.85M +$1.72M +48.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $8.9M $19.3M +$24.7M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$15.8M -$3.13M -$845K -37% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$14.9M -$3.74M +$2.93M +43.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$17.9M -$3.57M +$632K +15.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$18.5M -$5.33M +$5.91M +52.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$24.4M -$2.29M +$3.19M +58.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$27.6M -$6.67M -$7.06M -1779% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 -$20.5M -$4.2M +$238K +5.36% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$20.8M -$11.2M -$7.09M -171% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$13.7M -$5.48M -$7.14M -428% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$6.52M $397K +$106K +36.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 -$6.63M -$4.44M -$877K -24.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$5.75M -$4.15M +$3.59M +46.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$9.35M $1.67M +$8.93M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$18.3M $291K +$5.73M Oct 1, 2019 Dec 31, 2019 10-K 2020-03-12
Q3 2019 -$24M -$3.56M +$1.76M +33.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 -$25.8M -$7.74M +$719K +8.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$26.5M -$7.26M -$25K -0.35% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-01
Q4 2018 -$26.5M -$5.43M +$7.87M +59.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$34.3M -$5.32M +$6.12M +53.5% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$40.4M -$8.46M -$8.91M -1980% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$31.5M -$7.24M +$51.9M +87.8% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$83.4M -$13.3M -$10.7M -407% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 -$72.8M -$11.4M -$4.15M -56.9% Jul 1, 2017 Sep 30, 2017 10-Q/A 2019-03-18
Q2 2017 -$68.6M $450K +$11.3M Apr 1, 2017 Jun 30, 2017 10-Q/A 2019-03-18
Q1 2017 -$79.9M -$59.1M -$50.6M -588% Jan 1, 2017 Mar 31, 2017 10-Q/A 2019-03-18
Q4 2016 -$29.4M -$2.62M -$75.5M -104% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 $46.2M -$7.29M -$3.47M -90.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $49.6M -$10.9M -$5.78M -114% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $55.4M -$8.6M -$2.63M -44% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $58M $72.9M +$81.4M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 -$23.3M -$3.82M +$4.19M +52.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$27.5M -$5.07M +$1.05M +17.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$28.6M -$5.97M +$1.37M +18.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$29.9M -$8.47M +$2.42M +22.2% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$32.4M -$8.01M -$2.26M -39.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$30.1M -$6.12M +$718K +10.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$30.8M -$7.35M -$3.02M -70% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$27.8M -$10.9M -$1.01M -10.2% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-08
Q3 2013 -$26.8M -$5.75M -$268K -4.89% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$26.5M -$6.84M -$16.5M -171% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$10M -$4.32M +$1.58M +26.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$11.6M -$9.88M -$964K -10.8% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 -$10.7M -$5.48M +$3.4M +38.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$14.1M $9.64M +$23.3M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$37.4M -$5.9M -$852K -16.9% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$36.5M -$8.91M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-13
Q3 2011 -$8.88M -$6.4M -259% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 -$13.7M -$3.65M -36.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 -$5.05M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 -$2.47M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 -$10M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.